Vashadze Sh
Batumi State University after Sh. Rustaveli, Georgia.
Georgian Med News. 2011 Nov;11(200):63-7.
The Research purpose was studying anxiety and depression, and also the disturbing attacks in bronchial asthma (BA) patients. Research problems included: specification of prevalence of anxiety, depression, and also panic frustration of BA patients; an establishment of psychosomatic parities between anxiety, depression, panic frustration and BA. The study included the analysis of a mental condition, subjective and objective anamnestic information and medical documentation. 50 patients with BA are examined - 32 women, 18 men (average age of the patients was 38,7 ± 2,1). In 40% of cases the anxiety and depression is revealed. Subclinical expressed anxiety and depression is observed in 15 (39%) cases. Clinically expressed anxiety and depression is observed in 25 (50%) patients. During emotional and physical activities the phenomena of hypersthenic weaknesses is revealed in 45% of patients, short-term disturbance of falling asleep in 53%, propensity to revealing of polymorphic pathological corporal sensations (cephalgia, cardialgia, abdominalgia) is found out in 85% of cases. In all observation the beginning of mental frustration concerns to the second decade of life. In intervals between panic attacks are registered anxiety of expectation (fear of development of repeated panic attacks) and nosophobia (fear of development of myocardial heart attack, a stroke etc.). In all observation the beginning of mental frustration was revealed at the second decade of life. Symptoms of type "behavioral apnea (wind)" (breath dissatisfaction, feeling short of breath, arrhythmias and respiratory regularity of cycles) developed long before the manifestation of asthma (BA) and persist in its remission. The clinical manifestation of BA is extended by signs of panic attacks. Symptoms of anxiety and recurrent panic attacks worsen duration and outcome of BA. Hence, psychological and psychopharmacological therapy for anxiety disorders in addition to standard anti-asthma therapy could be suggested as one of the affective methods for treatment of BA patients with symptoms of anxiety and depression.
研究目的是研究支气管哮喘（BA）患者的焦虑和抑郁，以及困扰发作情况。研究问题包括：明确BA患者焦虑、抑郁以及惊恐障碍的患病率；确立焦虑、抑郁、惊恐障碍与BA之间的心身关系。该研究对精神状况、主观和客观的既往史信息以及医疗记录进行了分析。对50例BA患者进行了检查，其中32名女性，18名男性（患者平均年龄为38.7±2.1岁）。40%的病例中发现焦虑和抑郁。15例（39%）观察到亚临床表达的焦虑和抑郁。25例（50%）患者观察到临床表达的焦虑和抑郁。在情绪和体力活动期间，45%的患者出现精力过盛性虚弱现象，53%的患者出现短期入睡障碍，85%的病例发现有多形性病理性身体感觉（头痛、心痛、腹痛）的倾向。在所有观察中，精神障碍始于生命的第二个十年。在惊恐发作的间歇期，记录到预期焦虑（害怕再次发作惊恐）和疾病恐怖症（害怕发生心肌梗死、中风等）。在所有观察中，精神障碍始于生命的第二个十年。“行为性呼吸暂停（风）”类型的症状（呼吸不满意、气短感、心律失常和呼吸周期规律性）早在哮喘（BA）表现之前就已出现，并在其缓解期持续存在。BA的临床表现因惊恐发作的体征而延长。焦虑和复发性惊恐发作的症状会使BA的病程和结局恶化。因此，除标准抗哮喘治疗外，针对焦虑症的心理和心理药物治疗可作为治疗有焦虑和抑郁症状的BA患者的有效方法之一。
